Bausch + Lomb Receives FDA Approval for enVista® Envy™ Full Range of[...]
Castle Biosciences to Release Third Quarter 2024 Financial Results and[...]
Jasper Therapeutics Reports Positive Data from SPOTLIGHT Study of[...]
10/14/2024 | Press release | Distributed by Public on 10/14/2024 05:09
Please select the service you want to use:
Smartlinks | Unicycive Therapeutics Inc. | News | Health | Biotechnology | Biotechnology | Science | Biotechnology | Research | Company News | Business Announcement | Products and Services | Securities Issuers | Biotechnology and Medical Research Companies | NYSE American | NYSE ARCA Equities | Nasdaq Capital Market | Cboe BZX Exchange | Cboe BYX Exchange | Cboe EDGA Exchange | Cboe EDGX Exchange | FINRA Alternative Display Facility (ADF) | Nasdaq BX | Nasdaq PSX | NYSE Chicago
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact